Efficacy and safety of denosumab for osteoporosis in patients with autoimmune liver diseases

MLA

Shunji Hirose, et al. “Efficacy and Safety of Denosumab for Osteoporosis in Patients with Autoimmune Liver Diseases.” Kanzo, vol. 58, Jan. 2017, pp. 351–53. EBSCOhost, https://doi.org/10.2957/kanzo.58.351.

APA

Shunji Hirose, Koichi Shiraishi, Yoshitaka Arase, Kazuya Anzai, Tatehiro Kagawa, Tetsuya Mine, & Kota Tsuruya. (2017). Efficacy and safety of denosumab for osteoporosis in patients with autoimmune liver diseases. Kanzo, 58, 351–353. https://doi.org/10.2957/kanzo.58.351

Chicago

Shunji Hirose, Koichi Shiraishi, Yoshitaka Arase, Kazuya Anzai, Tatehiro Kagawa, Tetsuya Mine, and Kota Tsuruya. 2017. “Efficacy and Safety of Denosumab for Osteoporosis in Patients with Autoimmune Liver Diseases.” Kanzo 58 (January): 351–53. doi:10.2957/kanzo.58.351.